Get the Stockscreener App
9.40
0.43%
0.04
After Hours:
9.40
Anavex Life Sciences Corporation stock is traded at $9.40, with a volume of 702.00K.
It is up +0.43% in the last 24 hours and down -13.68% over the past month.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
See More
Previous Close:
$9.36
Open:
$9.45
24h Volume:
702.00K
Relative Volume:
0.70
Market Cap:
$807.40M
Revenue:
-
Net Income/Loss:
$-48.17M
P/E Ratio:
-16.49
EPS:
-0.57
Net Cash Flow:
$-37.10M
1W Performance:
-2.49%
1M Performance:
-13.68%
6M Performance:
+7.67%
1Y Performance:
+69.06%
1-Day Range:
$9.18
$9.51
1-Week Range:
$9.10
$9.93
52-Week Range:
$4.9301
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Name
Anavex Life Sciences Corporation
Sector
Industry
Phone
844-689-3939
Address
630 5TH AVENUE, NEW YORK
Compare AVXL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
9.40 | 803.97M | 0 | -48.17M | -37.10M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-23-22 | Initiated | Berenberg | Buy |
| Sep-23-21 | Initiated | BTIG Research | Buy |
| Dec-16-20 | Reiterated | H.C. Wainwright | Buy |
| Sep-28-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-27-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-18-19 | Initiated | Janney | Buy |
| May-16-18 | Resumed | Maxim Group | Buy |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-13-18 | Reiterated | Maxim Group | Buy |
| Sep-29-17 | Resumed | Noble Financial | Buy |
| Feb-07-17 | Initiated | Noble Financial | Buy |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
View All
Anavex Life Sciences Corporation Stock (AVXL) Latest News
Anavex Life Sciences Corp. stock trend forecastQuarterly Risk Review & Accurate Entry and Exit Point Alerts - Newser
Has Anavex Life Sciences Corp. found a price floor2025 Growth vs Value & Daily Momentum Trading Reports - Newser
What is the earnings history of Anavex Life Sciences Corp.Quarterly Trade Review & Weekly Setup with ROI Potential - خودرو بانک
Is Anavex Life Sciences Corp.’s growth already priced in2025 Retail Activity & Precise Swing Trade Alerts - خودرو بانک
How to track smart money flows in Anavex Life Sciences Corp.M&A Rumor & Risk Managed Investment Entry Signals - Newser
Using data tools to time your Anavex Life Sciences Corp. exitTrade Volume Report & Long-Term Safe Investment Ideas - Newser
How institutional ownership impacts Anavex Life Sciences Corp. stockTrade Entry Report & Accurate Technical Buy Alerts - Newser
Sector ETF performance correlation with Anavex Life Sciences Corp.Portfolio Performance Report & Real-Time Stock Movement Alerts - Newser
Pattern recognition hints at Anavex Life Sciences Corp. upside2025 Price Momentum & Reliable Trade Execution Plans - Newser
Anavex Life Sciences Corp. stock volume spike explainedMarket Activity Report & Consistent Profit Trading Strategies - Newser
Is this a good reentry point in Anavex Life Sciences Corp.2025 Market Sentiment & Fast Moving Stock Trade Plans - Newser
Trend analysis for Anavex Life Sciences Corp. this weekPortfolio Update Summary & Reliable Intraday Trade Plans - Newser
Price action breakdown for Anavex Life Sciences Corp.July 2025 Chart Watch & Safe Entry Point Identification - Newser
Using data models to predict Anavex Life Sciences Corp. stock movementEarnings Overview Summary & Expert Approved Momentum Ideas - Newser
What does recent volatility data suggest for Anavex Life Sciences Corp.Portfolio Gains Summary & Expert Curated Trade Setups - Newser
What MACD signals say about Anavex Life Sciences Corp.IPO Watch & Risk Managed Investment Strategies - Newser
How is Anavex Life Sciences Corp. managing supply chain issuesWeekly Stock Summary & Free Technical Confirmation Trade Alerts - خودرو بانک
Using Bollinger Bands to evaluate Anavex Life Sciences Corp.July 2025 Short Interest & Entry Point Confirmation Alerts - Newser
Multi asset correlation models including Anavex Life Sciences Corp.Day Trade & Community Consensus Trade Alerts - Newser
Chart based analysis of Anavex Life Sciences Corp. trendsGlobal Markets & Risk Managed Investment Signals - Newser
Is Anavex Life Sciences Corp. stock poised for growth2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser
Price momentum metrics for Anavex Life Sciences Corp. explainedJuly 2025 Outlook & Growth Oriented Trade Recommendations - Newser
Statistical indicators supporting Anavex Life Sciences Corp.’s strength2025 Macro Impact & AI Forecasted Stock Moves - Newser
Published on: 2025-09-03 23:07:21 - Newser
How to use Fibonacci retracement on Anavex Life Sciences Corp.Market Activity Recap & Free Weekly Chart Analysis and Trade Guides - Newser
Sentiment analysis tools applied to Anavex Life Sciences Corp.Bond Market & Weekly Momentum Stock Picks - Newser
Is Anavex Life Sciences Corp. forming a double bottom2025 Performance Recap & Low Volatility Stock Suggestions - خودرو بانک
Anavex Life Sciences Corp. stock outlook for YEAR2025 Earnings Impact & High Conviction Trade Alerts - Newser
What’s the beta of Anavex Life Sciences Corp. stockJuly 2025 Price Swings & Weekly Chart Analysis and Trade Guides - خودرو بانک
Using R and stats models for Anavex Life Sciences Corp. forecasting2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
Using AI based signals to follow Anavex Life Sciences Corp.Weekly Investment Report & Free Growth Oriented Trading Recommendations - Newser
Can technical indicators confirm Anavex Life Sciences Corp.’s reversalMarket Sentiment Summary & Risk Controlled Stock Pick Alerts - Newser
Why is Anavex Life Sciences Corp. stock going downJuly 2025 PostEarnings & Risk Managed Trade Strategies - خودرو بانک
Levi & Korsinsky Reminds Anavex Life Sciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024AVXL - ACCESS Newswire
Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025 - The Manila Times
CNS Drug Developer Anavex Life Sciences to Showcase Pipeline at Major Investment Conference - Stock Titan
Anavex Life Sciences Corporation Stock (AVXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):